Drugs & TargetsFree FDA grants accelerated approval to Talvey for R/R multiple myeloma August 11, 2023Vol.49 No.32
Drugs & TargetsFree FDA approves companion diagnostic to Ayvakit in gastrointestinal stromal tumors August 11, 2023Vol.49 No.32
Drugs & Targets FDA approves Jemperli with chemotherapy for endometrial cancer August 04, 2023Vol.49 No.31
Drugs & Targets FDA approves Lonsurf with bevacizumab for previously treated metastatic colorectal cancer August 04, 2023Vol.49 No.31
In Brief Patient Engagement Collaborative calls for applications for members July 21, 2023Vol.49 No.29
Drugs & Targets FDA grants Ambrx Fast Track designation for prostate cancer ADC therapy July 21, 2023Vol.49 No.29
